AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 363108 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (donor transplant 0.5 mm larger than recipient bed)
Number of subjects: 92
Study 363108 — intervention group
Group type: COMPARATOR
Intervention: Group B (donor buttons equal in size to recipient bed)
Number of subjects: 92
Study 31252284 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise (NME) for six months
Number of subjects: 0
Study 31252284 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 28336740 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment (IAT)
Number of subjects: 0
Study 28336740 — intervention group
Group type: COMPARATOR
Intervention: Without intra-arterial treatment (IAT)
Number of subjects: 0
Study 25337976 — intervention group
Group type: COMPARATOR
Intervention: Control scenario (white male)
Number of subjects: 113
Study 25337976 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental scenario (black male)
Number of subjects: 113
Study 25337976 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental scenario (white female)
Number of subjects: 113
Study 24488919 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol, D-chiro-inositol, folic acid and manganese (MDFM)
Number of subjects: 48
Study 24488919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 22960584 — intervention group
Group type: EXPERIMENTAL
Intervention: Semidemand method for nipple feeding
Number of subjects: 86
Study 22960584 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 86
Study 19453310 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine treatment
Number of subjects: 935
Study 17323070 — intervention group
Group type: COMPARATOR
Intervention: Cycling at a constant power output of 75 W (P1)
Number of subjects: 48
Study 17323070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling with power output alternating between 50 and 100 W every 5 min (P2)
Number of subjects: 48
Study 17323070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling with power output alternating in reverse order (P3)
Number of subjects: 48
Study 17323070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling with power output alternating between 25 and 125 W (P4)
Number of subjects: 48
Study 14699486 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (bolus of 4.8 microg/kg plus infusion of 9.6 microg x kg(‐1) x h(‐1)) at high intragastric volume (75% of threshold volume for discomfort)
Number of subjects: 21
Study 14699486 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg/kg) at high intragastric volume
Number of subjects: 21
Study 14699486 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg/kg) at low intragastric volume (perception threshold)
Number of subjects: 21
Study 14699486 — intervention group
Group type: COMPARATOR
Intervention: Low intragastric volume
Number of subjects: 21
Study 12439364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam (a selective dopamine receptor agonist) used as an adjunct during PCI for prevention of radiocontrast nephropathy (RCN)
Number of subjects: 0
Study 12439364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam in diabetics with moderate renal failure
Number of subjects: 0
Study 9676896 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum smoking
Number of subjects: 0
Study 9676896 — intervention group
Group type: COMPARATOR
Intervention: Deprivation
Number of subjects: 0
Study 9676896 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking after deprivation
Number of subjects: 0
Study 9676896 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking during the session
Number of subjects: 0
Study 8007592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine therapy
Number of subjects: 0
Study 8007592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine therapy with physiological infusion of vasopressin
Number of subjects: 0
Study 2707322 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening condition (counting targets)
Number of subjects: 0
Study 2707322 — intervention group
Group type: COMPARATOR
Intervention: Reading condition (ignoring stimuli)
Number of subjects: 0
Study 2707322 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotic listening with speech masker
Number of subjects: 0
Study 373073 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg trimipramine
Number of subjects: 9
Study 373073 — intervention group
Group type: COMPARATOR
Intervention: 25 mg trimipramine
Number of subjects: 9
Study 373073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31805614 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief mindfulness training program (four sessions)
Number of subjects: 103
Study 31805614 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 103
Study 31099085 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3 + 2000 mg calcium/d (n = 73)
Number of subjects: 149
Study 31099085 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 76)
Number of subjects: 149
Study 28973065 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic ICU admission program (n=1519 participants)
Number of subjects: 3037
Study 28973065 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (n=1518 participants)
Number of subjects: 3037
Study 25637380 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (arm A): FEC100 (500, 100, and 500 mg/m(2) for 3 cycles) followed by docetaxel (100 mg/m(2) for 3 cycles)
Number of subjects: 264
Study 25637380 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted treatment (arm B): 2 cycles of FEC100, switch to docetaxel if tumor size decreased by <30% after 2 cycles or <50% after 4 cycles; otherwise, FEC100 for six cycles before surgery
Number of subjects: 264
Study 23382321 — intervention group
Group type: EXPERIMENTAL
Intervention: Water ingestion with LBNP
Number of subjects: 12
Study 23382321 — intervention group
Group type: COMPARATOR
Intervention: LBNP
Number of subjects: 12
Study 21392667 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) followed by transpalatal arch (TPA) therapy and extraction of deciduous canines
Number of subjects: 70
Study 21392667 — intervention group
Group type: COMPARATOR
Intervention: No orthodontic treatment (control group)
Number of subjects: 70
Study 19443338 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation chemotherapy with docetaxel plus gemcitabine and concomitant treatment with docetaxel plus carboplatin plus 60 Gy TRT
Number of subjects: 139
Study 19443338 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with docetaxel plus gemcitabine and concomitant treatment with docetaxel plus carboplatin plus 60 Gy TRT
Number of subjects: 139
Study 19443338 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of RT treatment
Number of subjects: 139
Study 19443338 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of induction or consolidation plus concomitant treatment
Number of subjects: 139
Study 18633754 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg/day for three months
Number of subjects: 12
Study 18633754 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 12
Study 14985686 — intervention group
Group type: EXPERIMENTAL
Intervention: New prediction equation for REE
Number of subjects: 239
Study 14985686 — intervention group
Group type: COMPARATOR
Intervention: Existing formulae for predicting REE
Number of subjects: 239
Study 12815786 — intervention group
Group type: EXPERIMENTAL
Intervention: MAG i.v. group (25 patients) received daily doses of 2.5 ml of 20% MgSO4 per each 500 ml of transfused fluids for 5 days (day of surgery + 4 days post-surgery)
Number of subjects: 67
Study 12815786 — intervention group
Group type: COMPARATOR
Intervention: NORMO group (20 patients) with normal serum magnesium levels
Number of subjects: 67
Study 12815786 — intervention group
Group type: COMPARATOR
Intervention: HYPO group (22 patients) who developed hypomagnesaemia postoperatively
Number of subjects: 67
Study 9339388 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine
Number of subjects: 24
Study 9339388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8170750 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization plus Danjeon breathing
Number of subjects: 48
Study 8170750 — intervention group
Group type: EXPERIMENTAL
Intervention: Danjeon breathing
Number of subjects: 48
Study 8170750 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 3952518 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednimustine (PM)
Number of subjects: 217
Study 3952518 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide-vincristine-prednisolone (CVP)
Number of subjects: 217
Study 11150431 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cisplatin (200 mg/m² per cycle) with etoposide and bleomycin
Number of subjects: 74
Study 11150431 — intervention group
Group type: COMPARATOR
Intervention: Standard dose cisplatin (100 mg/m² per cycle) with etoposide and bleomycin
Number of subjects: 74
Study 11150431 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial Resection
Number of subjects: 74
Study 11150431 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed Resection
Number of subjects: 74
Study 11150431 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Resection
Number of subjects: 74
Study 11150431 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Resection
Number of subjects: 74
Study 11150431 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy Only
Number of subjects: 74
Study 31243790 — intervention group
Group type: COMPARATOR
Intervention: DS-1040 single ascending doses (50, 100, 200, or 400 mg)
Number of subjects: 56
Study 31243790 — intervention group
Group type: COMPARATOR
Intervention: DS-1040 multiple ascending doses (100 mg once daily, 200 mg once daily, or 150 mg twice daily)
Number of subjects: 56
Study 31243790 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1040 single and multiple doses
Number of subjects: 56
Study 31243790 — intervention group
Group type: COMPARATOR
Intervention: DS-1040
Number of subjects: 56
Study 31243790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 28446382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER)
Number of subjects: 35
Study 28446382 — intervention group
Group type: COMPARATOR
Intervention: Continuous energy restriction (CER)
Number of subjects: 35
Study 26575283 — intervention group
Group type: EXPERIMENTAL
Intervention: Support-giving condition (writing a supportive note to a friend)
Number of subjects: 0
Study 26575283 — intervention group
Group type: COMPARATOR
Intervention: Control condition (writing about their route to school/work)
Number of subjects: 0
Study 24898233 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily breakfast (≥700 kcal before 1100)
Number of subjects: 33
Study 24898233 — intervention group
Group type: COMPARATOR
Intervention: Extended fasting (0 kcal until 1200)
Number of subjects: 33
Study 22358132 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM plus adefovir (ADV) therapy
Number of subjects: 53
Study 22358132 — intervention group
Group type: COMPARATOR
Intervention: ETV monotherapy
Number of subjects: 53
Study 20585300 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 37
Study 20585300 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Endurance and Resistance Training (CT)
Number of subjects: 37
Study 20585300 — intervention group
Group type: COMPARATOR
Intervention: No exercise (Control)
Number of subjects: 37
Study 17336025 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional disclosure intervention
Number of subjects: 40
Study 17336025 — intervention group
Group type: COMPARATOR
Intervention: Time management control condition
Number of subjects: 40
Study 16244278 — intervention group
Group type: EXPERIMENTAL
Intervention: Bellows system (intervention group)
Number of subjects: 113
Study 16244278 — intervention group
Group type: COMPARATOR
Intervention: Non-bellows system (control group)
Number of subjects: 113
Study 12001038 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg; n=22)
Number of subjects: 41
Study 12001038 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (n=19)
Number of subjects: 41
Study 10449693 — intervention group
Group type: EXPERIMENTAL
Intervention: Active hormone preparations
Number of subjects: 365
Study 10449693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study 7794146 — intervention group
Group type: EXPERIMENTAL
Intervention: Seminar on rational prescribing of antibiotics
Number of subjects: 0
Study 7794146 — intervention group
Group type: EXPERIMENTAL
Intervention: Seminar on rational prescribing of benzodiazepines
Number of subjects: 0
Study 2244420 — intervention group
Group type: EXPERIMENTAL
Intervention: PDO by Tissucol
Number of subjects: 0
Study 2244420 — intervention group
Group type: EXPERIMENTAL
Intervention: PDO by Ethibloc
Number of subjects: 0
Study 2244420 — intervention group
Group type: COMPARATOR
Intervention: Non-occluded pancreases
Number of subjects: 0
Study 340975 — intervention group
Group type: EXPERIMENTAL
Intervention: Deanol
Number of subjects: 29
Study 340975 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 29
Study 340975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31564144 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented VEPE component
Number of subjects: 42
Study 31564144 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyethylene (PE) component
Number of subjects: 42
Study 29263353 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day intensive inpatient spa therapy (2 hr/day), exercise (30 min/day), and education (45 min/day)
Number of subjects: 88
Study 29263353 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 88
Study 25837016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous plus oral pantoprazole therapy (n=252)
Number of subjects: 504
Study 25837016 — intervention group
Group type: COMPARATOR
Intervention: Oral pantoprazole alone (n=252)
Number of subjects: 504
Study 25837016 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 504
Study 23600534 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoset Resmed A‐CPAP
Number of subjects: 79
Study 23600534 — intervention group
Group type: EXPERIMENTAL
Intervention: Remstar Auto Respironics A‐CPAP
Number of subjects: 79
Study 23600534 — intervention group
Group type: COMPARATOR
Intervention: Both A‐CPAP devices
Number of subjects: 79
Study 21355700 — intervention group
Group type: EXPERIMENTAL
Intervention: Four unannounced spaced clinical case-based tests (CCTs) over 2 months
Number of subjects: 19
Study 21355700 — intervention group
Group type: COMPARATOR
Intervention: One intermediate test at 6 weeks (Control)
Number of subjects: 19
Study 21355700 — intervention group
Group type: EXPERIMENTAL
Intervention: Final retention test identical to the pre-test at 2 months (both groups)
Number of subjects: 19
Study 19156149 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapericardial bleomycin (BLM) at 15 mg, followed by additional i.p.c. BLM 10 mg every 48 hours.
Number of subjects: 79
Study 19156149 — intervention group
Group type: COMPARATOR
Intervention: Observation alone after drainage (Control group).
Number of subjects: 79
Study 17573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Clove oil 1% cream
Number of subjects: 55
Study 17573751 — intervention group
Group type: COMPARATOR
Intervention: Control (stool softeners and lignocaine cream 5%)
Number of subjects: 55
Study 15488040 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 gauge (G) needle without filter
Number of subjects: 54
Study 15488040 — intervention group
Group type: EXPERIMENTAL
Intervention: 21 gauge (G) needle without filter
Number of subjects: 54
Study 15488040 — intervention group
Group type: EXPERIMENTAL
Intervention: 19G filtered needle
Number of subjects: 54
Study 15488040 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 18G and 21G groups of 2-mL ampoules
Number of subjects: 54
Study 11425836 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 400 microg on days 1, 3 and 5
Number of subjects: 60
Study 11425836 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 60
Study 9407576 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychogeriatric intervention (multidisciplinary joint treatment by a psychogeriatric team)
Number of subjects: 237
Study 9407576 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychogeriatric intervention
Number of subjects: 237
Study 9407576 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 237
Study 8485530 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate nonparametric tests based on ranks
Number of subjects: 0
Study 8485530 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual tests for carry-over effects and direct treatment effects
Number of subjects: 0
Study 8485530 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate response analysis
Number of subjects: 0
Study 3113243 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms
Number of subjects: 140
Study 3113243 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 100 micrograms
Number of subjects: 140
Study 3113243 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 50 micrograms
Number of subjects: 140
Study 3113243 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 25 micrograms
Number of subjects: 140
Study 3113243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 31142067 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 1 mg/kg intravenously for half an hour before operation and lidocaine for periprostatic nerve block (PNB)
Number of subjects: 166
Study 31142067 — intervention group
Group type: COMPARATOR
Intervention: Normal saline combined with PNB
Number of subjects: 166
Study 28248620 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-tobacco advertisements with disgust images
Number of subjects: 50
Study 28248620 — intervention group
Group type: COMPARATOR
Intervention: Anti-tobacco advertisements with smoking cues
Number of subjects: 50
Study 28248620 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of smoking cues and disgust content
Number of subjects: 50
Study 25909652 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for 6 weeks
Number of subjects: 29
Study 25909652 — intervention group
Group type: COMPARATOR
Intervention: Sham IMT protocol
Number of subjects: 29
Study 22929086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy for suicidal older men
Number of subjects: 33
Study 22929086 — intervention group
Group type: COMPARATOR
Intervention: Veterans Affairs Behavioral Health Laboratory recruitment
Number of subjects: 33
Study 21554734 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 21554734 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Strategic Therapy (BST)
Number of subjects: 0
Study 18651544 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 3
Study 18651544 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 3
Study 18651544 — intervention group
Group type: COMPARATOR
Intervention: Control group (no erythropoietin)
Number of subjects: 3
Study 16519637 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent haemorrhoidectomy
Number of subjects: 50
Study 16519637 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 50
Study 14642022 — intervention group
Group type: EXPERIMENTAL
Intervention: 11-item KADS
Number of subjects: 106
Study 14642022 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-length KADS
Number of subjects: 106
Study 14642022 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-item KADS
Number of subjects: 106
Study 14642022 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-rated scales (CDRS-R, CGI, GAF)
Number of subjects: 106
Study 10229902 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment, 0.05U/kg/day or a maximum of 3U/day s.c., reduced to 0.024±0.004U/kg/day due to side effects.
Number of subjects: 16
Study 10229902 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 16
Study 8698357 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hIFN-beta 1 x 10(6) IU/day
Number of subjects: 25
Study 8698357 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hIFN-beta 33,000 IU/day
Number of subjects: 25
Study 8698357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2055059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory rate at 8 cycles/min
Number of subjects: 6
Study 2055059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory rate at 16 cycles/min
Number of subjects: 6
Study 2055059 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ventilatory rates (8 and 16 cycles/min)
Number of subjects: 6
Study 2055059 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 secs of apnea in patients
Number of subjects: 6
Study 6852357 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone‐17,21‐dipropionate + 2% salicylic acid
Number of subjects: 40
Study 6852357 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone‐17,21‐dipropionate
Number of subjects: 40
Study 6852357 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% salicylic acid
Number of subjects: 40
Study 6852357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31615800 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (MH) group (33°C≤T°C≤34°C)
Number of subjects: 334
Study 31615800 — intervention group
Group type: COMPARATOR
Intervention: Normothermia group (36°C≤T°C≤37°C)
Number of subjects: 334
Study 26324729 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting insecticide-treated nets (LLIN)
Number of subjects: 655
Study 23323567 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg once daily in the morning
Number of subjects: 39
Study 23323567 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene 60 mg once daily in the evening
Number of subjects: 39